These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22849881)

  • 1. Impact of hospital-acquired Clostridium difficile.
    Lipp MJ; Nero DC; Callahan MA
    J Gastroenterol Hepatol; 2012 Nov; 27(11):1733-7. PubMed ID: 22849881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The financial impact of hospital-acquired conditions.
    Nero DC; Lipp MJ; Callahan MA
    J Health Care Finance; 2012; 38(3):40-9. PubMed ID: 22515043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vital signs: preventing Clostridium difficile infections.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Mar; 61(9):157-62. PubMed ID: 22398844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review.
    Gabriel L; Beriot-Mathiot A
    J Hosp Infect; 2014 Sep; 88(1):12-21. PubMed ID: 24996516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commentary: preventing Clostridium difficile-associated disease: is it time to pay the piper?
    Perencevich EN; Thom KA
    Infect Control Hosp Epidemiol; 2008 Sep; 29(9):829-31. PubMed ID: 18643747
    [No Abstract]   [Full Text] [Related]  

  • 6. Burden of Clostridium difficile Infections in French Hospitals in 2014 From the National Health Insurance Perspective.
    Leblanc S; Blein C; Andremont A; Bandinelli PA; Galvain T
    Infect Control Hosp Epidemiol; 2017 Aug; 38(8):906-911. PubMed ID: 28756805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic impact of Clostridium difficile infection in a multihospital cohort of academic health centers.
    Pakyz A; Carroll NV; Harpe SE; Oinonen M; Polk RE
    Pharmacotherapy; 2011 Jun; 31(6):546-51. PubMed ID: 21923438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods.
    Roberts RR; Scott RD; Hota B; Kampe LM; Abbasi F; Schabowski S; Ahmad I; Ciavarella GG; Cordell R; Solomon SL; Hagtvedt R; Weinstein RA
    Med Care; 2010 Nov; 48(11):1026-35. PubMed ID: 20940650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative impact of hospital-acquired infections on medical costs, length of hospital stay and outcome between community hospitals and medical centres.
    Sheng WH; Wang JT; Lu DC; Chie WC; Chen YC; Chang SC
    J Hosp Infect; 2005 Mar; 59(3):205-14. PubMed ID: 15694977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed.
    Plowman R; Graves N; Griffin MA; Roberts JA; Swan AV; Cookson B; Taylor L
    J Hosp Infect; 2001 Mar; 47(3):198-209. PubMed ID: 11247680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excess length of stay and mortality due to Clostridium difficile infection: a multi-state modelling approach.
    van Kleef E; Green N; Goldenberg SD; Robotham JV; Cookson B; Jit M; Edmunds WJ; Deeny SR
    J Hosp Infect; 2014 Dec; 88(4):213-7. PubMed ID: 25441017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs of nosocomial Clostridium difficile-associated diarrhoea.
    Vonberg RP; Reichardt C; Behnke M; Schwab F; Zindler S; Gastmeier P
    J Hosp Infect; 2008 Sep; 70(1):15-20. PubMed ID: 18602185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of hospital-onset Clostridium difficile infection in patients discharged from Rhode Island hospitals, 2010-2011: application of present on admission indicators.
    Jiang Y; Viner-Brown S; Baier R
    Infect Control Hosp Epidemiol; 2013 Jul; 34(7):700-8. PubMed ID: 23739074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inpatient Expenditures Attributable to Hospital-Onset Clostridium difficile Infection: A Nationwide Case-Control Study in Japan.
    Fukuda H; Yano T; Shimono N
    Pharmacoeconomics; 2018 Nov; 36(11):1367-1376. PubMed ID: 30022364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital cost of Clostridium difficile infection including the contribution of recurrences in French acute-care hospitals.
    Le Monnier A; Duburcq A; Zahar JR; Corvec S; Guillard T; Cattoir V; Woerther PL; Fihman V; Lalande V; Jacquier H; Mizrahi A; Farfour E; Morand P; Marcadé G; Coulomb S; Torreton E; Fagnani F; Barbut F;
    J Hosp Infect; 2015 Oct; 91(2):117-22. PubMed ID: 26253518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of Clostridium difficile infection on hospital readmissions and its potential impact under the Hospital Readmission Reduction Program.
    Chopra T; Neelakanta A; Dombecki C; Awali RA; Sharma S; Kaye KS; Patel P
    Am J Infect Control; 2015 Apr; 43(4):314-7. PubMed ID: 25838133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying sources of bias in National Healthcare Safety Network laboratory-identified Clostridium difficile infection rates.
    Haley VB; DiRienzo AG; Lutterloh EC; Stricof RL
    Infect Control Hosp Epidemiol; 2014 Jan; 35(1):1-7. PubMed ID: 24334790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost of Gram-negative resistance.
    Evans HL; Lefrak SN; Lyman J; Smith RL; Chong TW; McElearney ST; Schulman AR; Hughes MG; Raymond DP; Pruett TL; Sawyer RG
    Crit Care Med; 2007 Jan; 35(1):89-95. PubMed ID: 17110877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile.
    Kyne L; Hamel MB; Polavaram R; Kelly CP
    Clin Infect Dis; 2002 Feb; 34(3):346-53. PubMed ID: 11774082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attributable inpatient costs of recurrent Clostridium difficile infections.
    Dubberke ER; Schaefer E; Reske KA; Zilberberg M; Hollenbeak CS; Olsen MA
    Infect Control Hosp Epidemiol; 2014 Nov; 35(11):1400-7. PubMed ID: 25333435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.